Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study

Off-label use of rituximab is commonly requested for patients with resistant nephropathies. The outcomes and tolerability of rituximab in adult patients with nephropathy treated at our hospital (from 2013 to 2018) were described. Data were retrieved from electronic medical records. Response was clas...

Descripción completa

Detalles Bibliográficos
Autores principales: Sans-Pola, Carla, Agustí, Antònia, Bosch, Josep Àngel, Agraz, Irene, Alerany, Carmen, Danés, Immaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584949/
https://www.ncbi.nlm.nih.gov/pubmed/34768461
http://dx.doi.org/10.3390/jcm10214941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584949/
https://www.ncbi.nlm.nih.gov/pubmed/34768461
http://dx.doi.org/10.3390/jcm10214941

Ejemplares similares